To verify whether the activation of RTKs is related to the decreased invasive ability of invasive bladder cancer cells, we used the RayBio Human Receptor Tyrosine Kinases (RTKs) Phosphorylation Antibody Array to investigate the activation of RTKs in siNEU3-treated cells, and the phosphorylation status 71 receptor of non-RTKs were comprehensively analyzed. Here, NTRK1 is linked to urinary bladder carcinoma.